Stay updated on Fazirsiran in AATD Liver Disease Clinical Trial

Sign up to get notified when there's something new on the Fazirsiran in AATD Liver Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fazirsiran in AATD Liver Disease Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    ClinicalTrials.gov’s page footer was updated to reflect a new site release revision (from v3.5.2 to v3.5.3). This represents a technical/version update to the website interface rather than a change to the study record.
    Difference
    0.1%
    Check dated 2026-04-24T22:43:30.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:16:14.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now includes Alpha-1-antitrypsin deficiency as a topic and adds a Genetic and Rare Diseases Information Center resource under Resources.
    Difference
    0.2%
    Check dated 2026-04-03T05:45:04.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Removed Alpha 1-antitrypsin deficiency and the Genetic and Rare Diseases Information Center resources from the page.
    Difference
    0.2%
    Check dated 2026-03-27T02:20:57.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and Revision: v3.4.3 removed. This indicates a new version of the study documents (likely protocol/SPA) has been issued.
    Difference
    0.1%
    Check dated 2026-03-19T23:44:21.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T19:44:54.000Z thumbnail image

Stay in the know with updates to Fazirsiran in AATD Liver Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fazirsiran in AATD Liver Disease Clinical Trial page.